Audoin, C., Bonhomme, D., Ivanisevic, J., de la Cruz, M., Cautain, B., Monteiro, M.C., Reyes, F., Rios, L., Perez, T. and Thomas, O. (2013) Balibalosides, an original family of glucosylated sesterterpenes produced by the Mediterranean sponge Oscarella balibaloi. Marine Drugs 11, 1477–1489.
Bérdy, J. (2012) Thoughts and facts about antibiotics: where we are now and where we are heading. Journal of Antibiotics (Tokyo) 65, 385–395.
Blunt, J.W., Copp, B.R., Keyzers, R.A., Munro, M.H.G. and Prinsep, M.R. (2015) Marine natural products. Nature Product Report 32, 116–211.
Cambon-Bonavita, M.A., Raguenes, G., Jean, J., Vincent, P. and Guezennec, J. (2002) A novel polymer produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid. Journal of Applied Microbiology 93, 310–315.
Cunliffe, V.T. (2015) Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures. Journal of Neuroscience Methods. doi: 10.1016/j.jneumeth.2015.07.015.
Daly, N.L. and Craik, D.J. (2011) Conopeptides as novel options for pain management. Drugs Future 36, 25–32.
Dias, D.A., Urban, S. and Roessner, U. (2012) A historical overview of natural products in drug discovery. Metabolites 2, 303–336.
European Marine Board (2013) Linking oceans and human health: a strategic research priority for Europe. Ostend: Position paper 19 of the European Marine Board.
Fiedor, J. and Burda, K. (2014) Potential role of carotenoids as antioxidants in human health and disease. Nutrients 6, 466–488.
Gammone, M.A. and D'Orazio, N. (2015) Anti-obesity activity of the marine carotenoid fucoxanthin. Marine Drugs 13, 2196–2214.
Gerwick, W.H. and Moore, B.S. (2012) Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chemistry & Biology 19, 85–98.
Glaser, K.B. and Mayer, A.M. (2009) A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Biochemical Pharmacology 78, 440–448.
Hirata, Y. and Uemura, D. (1986) Halichondrins-antitumor polyether macrolides from a marine sponge. Pure and Applied Chemistry 58, 701–710.
Jang, H.J., Nam, S.-J., Locke, J.B., Kauffman, C.A., Beatty, D.S., Paul, L.A. and Fenical, W. (2013) Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angewandte Chemie International Edition 52, 7822–7824.
Katz, J., Janik, J.E. and Younes, A. (2011) Brentuximab Vedotin (SGN-35). Clinical Cancer Research 17, 6428–6436.
Klotz, U. (2006) Ziconotide – a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain – a short review. International Journal of Clinical Pharmacology and Therapy 44, 478–483.
Lacret, R., Oves-Costales, D., Gómez, C., Díaz, C., de la Cruz, M., Pérez-Victoria, I., Vicente, F., Genilloud, O. and Reyes, F. (2015) New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis. Marine Drugs 13, 128–140.
Lallier, L.E., McMeel, O., Greiber, T., Vanagt, T., Dobson, A.D. and Jaspars, M. (2014) Access to and use of marine genetic resources: understanding the legal framework. Natural Product Report 31, 612–616.
Larsson, D.G.K. (2014) Pollution from drug manufacturing: review and perspectives. Philosophical Transactions of the Royal Society B Biological Sciences 369, 20130571.
Leoutsakos, V. (2004) A short history of the thyroid gland. Hormones 3, 268–271.
Lorente, A., Makowski, K., Albericio, F. and Álvarez, M. (2014) Bioactive marine polyketides as potential and promising drugs. Annals of Marine Biology and Research 1, 1003.
Martins, A., Vieira, H., Gaspar, H. and Santos, S. (2014) Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success. Marine Drugs 12, 1066–1101.
Mayer, A.M.S., Glaser, K.B., Cuevas, C., Jacobs, R.S., Kem, W., Little, R.D., McIntosh, J.M., Newman, D.J., Potts, B.C. and Shuster, D.E. (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends in Pharmacology Science 31, 255–265.
Mayer, A.M.S., Rodríguez, A.D., Taglialatela-Scafati, O. and Fusetani, N. (2013) Marine pharmacology in 2009–2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Marine Drugs 11, 2510–2573.
Menis, J. and Twelves, C. (2011) Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer. Breast Cancer: Targets Therapy 3, 101–111.
Mora, C., Tittensor, D.P., Adl, S., Simpson, A.G.B. and Worm, B. (2011) How many species are there on earth and in the ocean? PLoS Biol 9, e1001127.
Newman, D.J. and Cragg, G.M. (2014) Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Marine Drugs 12, 255–278.
Potts, B.C., Albitar, M.X., Anderson, K.C., Baritaki, S., Berkers, C., Bonavida, B., Chandra, J., Chauhan, D., Cusack, J.C. Jr, Fenical, W., Ghobrial, I.M., Groll, M., Jensen, P.R., Lam, K.S., Lloyd, G.K., McBride, W., McConkey, D.J., Miller, C.P., Neuteboom, S.T., Oki, Y., Ovaa, H., Pajonk, F., Richardson, P.G., Roccaro, A.M., Sloss, C.M., Spear, M.A., Valashi, E., Younes, A. and Palladino, M.A. (2011) Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Current Cancer Drug Targets 11, 254–284.
Rangel, M. and Falkenberg, A. (2015) An overview of the marine natural products in clinical trials and on the market. Journal of Coastal Life Medicine 3, 421–428.
Rocha-Martin, J., Harrington, C., Dobson, A.D.W. and O'Gara, F. (2014) Emerging strategies and integrated systems microbiology technologies for biodiscovery of marine bioactive compounds. Marine Drugs 12, 3516–3559.
Sagar, S., Kaur, M. and Minneman, K.P. (2010) Antiviral lead compounds from marine sponges. Marine Drugs 8, 2619–2638.
Schoffski, P., Dumez, H., Wolter, P., Stefan, C., Wozniak, A., Jimeno, J. and Van Oosterom, A.T. (2008) Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. Expert Opinion on Pharmacotherapy 9, 1609–1618.
VanHook, A.M. (2010) Behavioural fingerprinting. Science Signaling 10, 3, pp. ec22.